• ProteoGenix renews ISO 9001 and ISO 14001 Certifications
    Others

    ProteoGenix renews ISO 9001 and ISO 14001 Certifications

    Ines Fraccia Ines Fraccia 4 min read

    ProteoGenix is proud to announce the renewal of its ISO 9001:2015 and ISO 14001:2015 Certifications, marking a new milestone in our ongoing commitment to…

  1. Antibody production

    What are chimeric antibodies?

    Read more
  2. Antibody-drug conjugates

    ADC payloads

    Read more
  3. Antibody production

    A guide on how to easily transition to a new antibody expression system kit

    Read more
  4. Antibody production

    The best CHO expression system kits on the market

    Read more
  5. Peptide synthesis

    How the discovery and consolidation of solid-phase peptide synthesis continue to boost the development of therapeutic peptides

    Read more

Let’s talk about science – Scientists in the spotlight

Dr. Louisa James

“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists”

Read more
Queen Mary University of London (QMUL, UK) Queen Mary University of London (QMUL, UK)
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists”
Dr. Mara Freire

Reinventing IgY biotherapeutics

Read more
CICECO, University of Aveiro CICECO, University of Aveiro
Reinventing IgY biotherapeutics
Dr. Melanie Conrad

How the environment shapes immune system development during pregnancy

Read more
Charité Medical University in Berlin Charité Medical University in Berlin
How the environment shapes immune system development during pregnancy
Dr. Mohamed Alfaleh

“Cell-based phage display is helping us isolate more biologically relevant antibodies”

Read more
King Abdulaziz University King Abdulaziz University
“Cell-based phage display is helping us isolate more biologically relevant antibodies”
Prof. Tomáš Kalina

“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation”

Read more
Charles University in Prague Charles University in Prague
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation”
Prof. Richard Pleass

“Antibodies will make a significant contribution to design effective control strategies for COVID-19”

Read more
LSTM LSTM
“Antibodies will make a significant contribution to design effective control strategies for COVID-19”
Professor Istvan Toth

“Simplicity is the key to successful large-scale applications”

Read more
Queensland University, Australia Queensland University, Australia
“Simplicity is the key to successful large-scale applications”
See More

Read by topic